Graves' Ophthalmopathy-Reply
- 1 August 1985
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 103 (8) , 1110-1112
- https://doi.org/10.1001/archopht.1985.01050080022006
Abstract
In Reply. —Dr Frueh is correct. Not only are "all the facts... not yet in," but those "facts" that are in are difficult to define, even in terms of reasonably scrutinizable data. Dr Frueh's patient is indeed fortunate to have had a reduction from 3 to 1 Δ of intermittent right hypertropia in primary gaze after more than eight months of high-dosage prednisone therapy that rendered her cushingoid, followed by irradiation therapy. Presumably, simple prismatic correction was not tolerated. There may well be other such cases or even more dramatic quantitative effects of orbital irradiation in gravesian ophthalmoplegia, but, until this elusive subset of treated patients surfaces for public inspection, we are compelled to exercise management protocols based on personal experience and the meager information available from published series. For example, Brennan et al1 concluded that "extraocular muscle restriction was least altered by radiation therapy," but there is noKeywords
This publication has 4 references indexed in Scilit:
- Radiation Therapy for Graves' DiseaseAmerican Journal of Ophthalmology, 1983
- Orbital Radiation for the Ocular Changes of Graves' DiseaseAmerican Journal of Ophthalmology, 1975
- Supervoltage Orbital Radiotherapy for Graves' Ophthalmopathy1Journal of Clinical Endocrinology & Metabolism, 1973
- Orbital X-ray Therapy of Progressive ExophthalmosThe British Journal of Radiology, 1951